Susan Hasty, Publisher
Table of Contents . . . May 31st, 2004
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Bioterrorism Week | Other Publications
Anthrax Vaccine - Membranal polypeptides of Bacillus anthracis identified
Influenza - Pandemic influenza can be contained with antiviral agents
Patents - Patent granted for CMX001, an orally-active smallpox therapeutic
Smallpox - Mass vaccination unnecessary in event of outbreak
Anthrax - NERD is DNA processing-related domain in anthrax virulence plasmid
Antiseptic Therapy - Anti-infective applications sought for antiseptic nasal spray product
Enzymology - Trypsin IV is a novel agonist of protease-activated receptors 2 and 4
Facilities - University of Iowa Hygienic Lab to expand capabilities
Finance - Affinitak maker reports decrease in revenues during first quarter
Finance - Safety-products maker reports increased sales in first quarter
Food-Borne Illness - Botulinum toxin structure offers clues for vaccines/treatments
Smallpox - Company receives development funding for smallpox vaccine
Smallpox - Third-generation vaccine against smallpox tested
Smallpox Vaccine - Method developed to monitor immune response against vaccinia virus
Smallpox Vaccine - Prevalence of dermatologic reactions to smallpox vaccine reported
Technology - New modeling grants target epidemics, bioterror
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.